Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2008-03-24

FDA Approved: CYCLOBENZAPRINE HYDROCHLORIDE — Supplemental Application (Amneal Pharmaceuticals of New York LLC)

View source ↗

Summary

The FDA approved a supplemental application for cyclobenzaprine hydrochloride from Amneal Pharmaceuticals of New York LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • CYCLOBENZAPRINE HYDROCHLORIDE (Cyclobenzaprine hydrochloride)

Snippet

SUPPL AP for CYCLOBENZAPRINE HYDROCHLORIDE (CYCLOBENZAPRINE HYDROCHLORIDE)